Annovis Bio, Inc. (NYSE:ANVS) filed a Form 8-K with the Securities and Exchange Commission on January 28, 2026, disclosing a material event.
Annovis Bio, Inc.'s stock currently trades at $3.04 with a market capitalization of $74.6M. The Healthcare company's stock moved following the disclosure.